Table 3 MicroRNAs differentially expressed between refractory (NR) and sensitive (CR) patients after Fludarabine treatment
From: MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
POST Treatment Differentially expressed microRNAs | |||||||
|---|---|---|---|---|---|---|---|
microRNA | p-value | Fold change absolute | Regulation NR/CR | NR average expression | CR average expression | Chromosome | Accession |
hsa-miR-138-2* | 0.0142 | 1.91 | down | 1.39 | 2.65 | chr16 | MIMAT0004596 |
hsa-miR-21* | 0.0168 | 3.11 | up | 9.60 | 3.09 | chr17 | MIMAT0004494 |
hsa-miR-148a | 0.0188 | 2.77 | up | 119.81 | 43.27 | chr7 | MIMAT0000243 |
hsa-miR-221* | 0.0212 | 1.96 | up | 9.75 | 4.97 | chrX | MIMAT0004568 |
hsa-miR-21 | 0.0244 | 2.29 | up | 15,079.56 | 6,580.23 | chr17 | MIMAT0000076 |
hsa-miR-192 | 0.0266 | 1.95 | up | 35.14 | 18.04 | chr11 | MIMAT0000222 |
hsa-miR-194 | 0.0378 | 2.20 | up | 17.70 | 8.04 | chr1 | MIMAT0000460 |
hsa-miR-801 | 0.0408 | 1.81 | up | 44.94 | 24.83 | chr1 | MIMAT0004209 |
hsa-miR-598 | 0.0428 | 2.18 | up | 9.88 | 4.53 | chr8 | MIMAT0003266 |
hsa-miR-20a* | 0.0448 | 1.99 | up | 37.27 | 18.77 | chr13 | MIMAT0004493 |
hsa-miR-222 | 0.0486 | 1.97 | up | 52.07 | 26.38 | chrX | MIMAT0000279 |